Belite Bio, Inc (BLTE) Cash from Operations (2024 - 2025)
Belite Bio (BLTE) posted quarterly Cash from Operations of 10385000.0 for Q4 2025, down 125.71% year-over-year from 40390012.68 in Q4 2024, and down 125.71% on a QoQ basis from 4601000.0 in Q4 2024.
Belite Bio, Inc (BLTE) Cash from Operations (2024 - 2025) Analysis & Trends
Belite Bio (BLTE) has reported Cash from Operations for 2 consecutive years, with 10385000.0 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.39 Mn |
| Dec 31, 2025 | -10.39 Mn |
| Dec 31, 2024 | -4.60 Mn |
| Dec 31, 2024 | -4.60 Mn |